Determinants of Cognitive Performance Among Ghanaian Hypertensive Patients: A Cross-Sectional Study

Solomon Gyabaah1, Samuel Nguah Blay1,2, Shadrack Osei Asibey1

  • 1Komfo Anokye Teaching Hospital Kumasi Ghana.

PubMed

Insights

Cognitive decline in hypertensive Ghanaians is linked to older age and female sex, but higher education improves cognitive performance. This highlights key factors influencing brain health in this population.

Area of Science:

  • Neurology
  • Public Health
  • Gerontology

Background:

  • Hypertension is a significant global health issue, particularly prevalent in sub-Saharan Africa with poor blood pressure control.
  • Cognitive decline is a serious consequence of hypertension, impacting quality of life and healthcare burdens.

Purpose of the Study:

  • To investigate the factors influencing cognitive performance in Ghanaian patients diagnosed with hypertension.
  • To identify specific demographic and clinical determinants associated with cognitive function in this population.

Main Methods:

  • A cross-sectional study involving 214 hypertensive adults (aged ≥18 years) at a district hospital.
  • Global cognitive performance was assessed using the Montreal Cognitive Assessment (MOCA).
  • Multivariable linear regression analysis identified independent predictors of MOCA scores.

Main Results:

  • Older age and female sex were independently associated with poorer cognitive performance (lower MOCA scores).
  • Higher levels of education (secondary and tertiary) were linked to better cognitive performance.
  • In sensitivity analyses, factors like BMI, heart failure, stroke history, and uncontrolled hypertension showed associations with cognitive scores, varying by sex.

Conclusions:

  • Age and female sex are risk factors for cognitive decline in hypertensive Ghanaians.
  • Educational attainment is a protective factor for cognitive function in this demographic.
  • Understanding these determinants is crucial for targeted interventions to preserve cognitive health in hypertensive individuals in Ghana.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
51
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
4.9K
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
45
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
40
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
85
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
80